A partnership between the Center for Forensic Science Research and Education (CFSRE) and the Philadelphia Department of Public Health (PDPH) has been established to accurately assess the drug supply in Philadelphia, Pennsylvania. This initiative was established as a comprehensive effort examining various drug materials and drug forms. Select drug testing results from samples obtained within the city were compiled for preparation of this report. The results reported herein represent a subset of the drug supply and not its entirety. The Drug Checking report is intended to help promote timely and appropriate public health and public safety preparedness and response.
Summary and Key Findings:
▶ 90 samples were reported between March and early-May 2022
▶ Most “heroin”/dope samples contained fentanyl and xylazine
▶ Fentanyl-xylazine (tranq-dope) proportions varied greatly
▶ para-Fluorofentanyl continues its presence in dope samples
▶ Two cocaine (coke) samples contained trace levels of fentanyl, while methamphetamine samples were not adulterated
▶ Two counterfeit oxycodone tablets contained fentanyl
▶ Tenocyclidine was detected in samples purported to be “PCP”
CLICK HERE TO ACCESS THE DRUG CHECKING REPORT
